Oncology Institute Inc Cash Flow Reinvestment Rate
Oncology Institute Inc cash flow reinvestment rate. Oncology Institute Inc (TOI) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting $1.06 Million (capex $1.06 Million ) from operating cash flow of $3.23 Million. Explore TOI operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Oncology Institute Inc (2018–2020)
Cash flow reinvestment rate of Oncology Institute Inc from 2018 to 2020. Historical reinvestment intensity for Oncology Institute Inc across 3 annual periods. Explore TOI capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Oncology Institute Inc Cash Flow Reinvestment Rate by Year (2018–2020)
Oncology Institute Inc cash flow reinvestment rate by year from 2018 to 2020. Year-by-year capital reinvestment analysis for Oncology Institute Inc. For the full cash flow conversion analysis, see Oncology Institute Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 19.76x | $10.04 Million | $508.00K | $1.19 Million | ▲ +2865.3% |
| 2019 | 0.67x | $2.41 Million | $3.62 Million | $1.20 Million | ▲ +18.1% |
| 2018 | 0.56x | $3.18 Million | $5.64 Million | $695.96K | — |